Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PsA Disease Activity Improves on GLP-1s A retrospective study presented at ACR Convergence 2025, led by researchers from the University of Toronto and NYU, followed 48 patients with psoriatic arthritis who started GLP-1 receptor agonists. The findings: Significant weight loss (35% of patients lost 510% of body weight
Conclusion A small drop after a GLP1 injection can happen and does not always mean you missed your dose
It is also used for fat-burning and increasing energy
The drug has a half-life of approximately five days, meaning that weekly dosing keeps active tirzepatide circulating continuously throughout each seven-day cycle
Owing to the shared conserved Rel homology domain, any two of these family members can form homo- or heterodimers
Larowe SD, Mardikian P, Malcolm R, et al
